The more you understand about primary immunodeficiency (PI), the better you can live with the disease or support others in your life with PI. Learn more about PI, including the various diagnoses and treatment options.
Living with primary immunodeficiency (PI) can be challenging, but you’re not alone—many people with PI lead full and active lives. With the right support and resources, you can, too.
Be a hero for those with PI. Change lives by promoting primary immunodeficiency (PI) awareness and taking action in your community through advocacy, donating, volunteering, or fundraising.
Whether you’re a clinician, researcher, or an individual with primary immunodeficiency (PI), IDF has resources to help you advance the field. Get details on surveys, grants, and clinical trials.
While many areas of medical care temporarily halted as the pandemic unfolded in 2020, newborn screening (NBS) programs across the United States didn’t have the luxury of ceasing their operations.
All babies in the United States undergo NBS when they are between two and three days old. During a screening, a blood sample is taken from a baby and analyzed to determine if a life-threatening medical problem exists. As part of NBS, a baby’s hearing and vision are also evaluated.
As babies continued to be born during the pandemic, they also continued to undergo NBS. And while the screening took place in-person, the processing and distribution of some of those evaluations shifted to virtual.
In a recently published report entitled, “Newborn Screening Continuity of Operations in a Pandemic: Use of Telehealth and Other Lessons Learned,” the Association of Public Health Laboratories (APHL) described how telehealth allowed NBS lab staff and providers to pivot from performing their duties in-person to accomplishing their roles virtually, resulting in the continuation of services to families. Surveys of newborn screening labs, healthcare providers, and families informed the report.
Telework allowed the labs and healthcare providers to accomplish the following:
“The ongoing COVID-19 pandemic highlighted the utility (and in some cases, necessity) of moving away from paper-based NBS results reporting (often accomplished via postal mail or fax) to electronic-based reporting options. Electronic availability of NBS results during the pandemic provided several benefits to NSP staff and external NBS stakeholders alike,” according to the report.
In addition, barriers and restrictions related to reimbursement for services were lifted, resulting in families’ greater access to clinicians, genetic counselors, and dieticians for NBS follow-up needs.
According to the report, providers used teleconferencing to:
The report also described how those with rare diseases experienced particular hardship when accessing medical services during the pandemic.
Despite the shift to virtual, 1 in 2 rare disease patients reported provider-initiated appointment cancellations, and 1 in 4 patients canceled the appointments themselves due to fear of the virus, according to the report. Families also experienced transportation challenges – an obstacle to accessing medical supplies, care, and treatment.
“All NBS disorders are life-long, often requiring careful coordination amongst numerous specialists and healthcare providers. Diagnosis and initial treatment are only the beginning of the family’s journey, followed by ongoing monitoring and interventions through the lifespan,” explained the report.
The APHL report concluded that the continuation of telehealth is essential to provide care for those with rare diseases, even when the pandemic subsides.
“A silver lining of the pandemic for the rare disease community was the expansion of telehealth services that allowed families to access care safely and effectively,” according to the report.
“Though the pandemic necessitated an increase in telehealth capabilities and access for providers and families, the benefits of telehealth are not limited to emergent situations and should continue to be an option for network service providers, medical providers, and families now and in the future.”
To read the full report, click here.
Receive news and helpful resources to your cell phone or inbox. You can change or cancel your subscription at any time.
The Immune Deficiency Foundation improves the diagnosis, treatment, and quality of life for every person affected by primary immunodeficiency.
We foster a community that is connected, engaged, and empowered through advocacy, education, and research.
Combined Charity Campaign | CFC# 66309